|
Real-time
Euronext Paris
07:31:45 2026-09-09 am EDT
|
5-day change | 1st Jan Change | ||
| 158.30 EUR | -0.57% |
|
-5.61% | +33.03% |
| Sep. 08 | Rubis posts gold-standard results, telecom operators talk, Novartis has to pull the parachute. |  |
| Aug. 21 | Ipsen S.A. completed the acquisition of Kartos Therapeutics, Inc. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 15.18B | |||||
| 1,002B | |||||
| 649B | - | - | - | ||
| 440B | |||||
| 346B | |||||
| 263B |
- Stock Market
- Stocks
- IPN Stock
- Charts Ipsen
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
